In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of
. India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing
Regulations), we wish to inform you that the Unaudited Financial Results (Standalone) of the
Company for the Quarter and Half-Year ended September 30, 2018 were approved by the
Board of Directors of the Company at its meeting held today.
Kappac Pharma: Submission Of Audited Financial Result For Quarter And Half-Year Ended September 30,2018 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015
November 5, 2018